# Efficacy and Safety of a Vaginal Ovule Medical Device for Bacterial Vaginosis and Candidal Vaginitis (ROVUL25).

> **NCT07703241** · NA · NOT_YET_RECRUITING · sponsor: **ROELMI HPC** · enrollment: 80 (estimated)

## Conditions studied

- Bacterial Vaginosis
- Candidal Vaginitis

## Interventions

- **DEVICE:** Class IIa vaginal medical device supplied as vaginal ovules, intended as an adjuvant in prevention of vaginal infections and symptoms.
- **OTHER:** Placebo.

## Key facts

- **NCT ID:** NCT07703241
- **Lead sponsor:** ROELMI HPC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-09
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07703241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07703241, "Efficacy and Safety of a Vaginal Ovule Medical Device for Bacterial Vaginosis and Candidal Vaginitis (ROVUL25).". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07703241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*